NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

Cash at last quarter end: 6.6m
Raised in subsequent events: 2.2m
Total operating costs Q2: 7.2m

Assuming no undisclosed fundraising, and Q3 costs similar to Q2, nwbo likely ended Q3 at around $1.6m in cash. That's less than a month at their ongoing burn rate.

Further fundraising should be expected based on nwbo's history and its own words in the 10-Q:

"The Company’s existing liquidity is not sufficient to fund its operations, anticipated capital expenditures, working capital and other financing requirements until the Company reaches significant revenues."

For better or worse, this is how Powers chooses to run the business.